Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

IL-13 effector functions.

Wynn TA.

Annu Rev Immunol. 2003;21:425-56. Epub 2001 Dec 19. Review.

PMID:
12615888
2.

IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs.

Chiaramonte MG, Schopf LR, Neben TY, Cheever AW, Donaldson DD, Wynn TA.

J Immunol. 1999 Jan 15;162(2):920-30.

3.

Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13.

Chapoval SP, Al-Garawi A, Lora JM, Strickland I, Ma B, Lee PJ, Homer RJ, Ghosh S, Coyle AJ, Elias JA.

J Immunol. 2007 Nov 15;179(10):7030-41.

4.

Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.

Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM, Foster PS.

Clin Exp Allergy. 2006 Dec;36(12):1575-83.

PMID:
17177681
5.

The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation.

Asquith KL, Ramshaw HS, Hansbro PM, Beagley KW, Lopez AF, Foster PS.

J Immunol. 2008 Jan 15;180(2):1199-206.

6.

Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.

Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M.

J Exp Med. 1995 Nov 1;182(5):1527-36.

7.

Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness--a murine model.

Hamelmann E, Tadeda K, Oshiba A, Gelfand EW.

Allergy. 1999 Apr;54(4):297-305. Review.

8.

Interleukin-9 upregulates mucus expression in the airways.

Louahed J, Toda M, Jen J, Hamid Q, Renauld JC, Levitt RC, Nicolaides NC.

Am J Respir Cell Mol Biol. 2000 Jun;22(6):649-56.

PMID:
10837360
9.

Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy.

Drouin SM, Corry DB, Hollman TJ, Kildsgaard J, Wetsel RA.

J Immunol. 2002 Nov 15;169(10):5926-33.

10.

IL-2 receptor beta-chain signaling controls immunosuppressive CD4+ T cells in the draining lymph nodes and lung during allergic airway inflammation in vivo.

Doganci A, Karwot R, Maxeiner JH, Scholtes P, Schmitt E, Neurath MF, Lehr HA, Ho IC, Finotto S.

J Immunol. 2008 Aug 1;181(3):1917-26.

11.

IL-13 as a therapeutic target for respiratory disease.

Kasaian MT, Miller DK.

Biochem Pharmacol. 2008 Jul 15;76(2):147-55. doi: 10.1016/j.bcp.2008.04.002. Epub 2008 Apr 16. Review.

PMID:
18502398
12.

IL-12/IL-13 axis in allergic asthma.

Wills-Karp M.

J Allergy Clin Immunol. 2001 Jan;107(1):9-18. Review.

PMID:
11149983
13.

Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection.

Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL, Morse HC 3rd.

Immunol Rev. 1992 Jun;127:183-204. Review.

PMID:
1354651
14.
15.

In vivo disruption of TGF-beta signaling by Smad7 in airway epithelium alleviates allergic asthma but aggravates lung carcinogenesis in mouse.

Luo X, Ding Q, Wang M, Li Z, Mao K, Sun B, Pan Y, Wang Z, Zang YQ, Chen Y.

PLoS One. 2010 Apr 13;5(4):e10149. doi: 10.1371/journal.pone.0010149.

16.

IL-12-STAT4-IFN-gamma axis is a key downstream pathway in the development of IL-13-mediated asthma phenotypes in a Th2 type asthma model.

Kim YS, Choi SJ, Choi JP, Jeon SG, Oh S-, Lee BJ, Gho YS, Lee CG, Zhu Z, Elias JA, Kim YK.

Exp Mol Med. 2010 Aug 31;42(8):533-46.

17.

Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation.

Kumar M, Ahmad T, Sharma A, Mabalirajan U, Kulshreshtha A, Agrawal A, Ghosh B.

J Allergy Clin Immunol. 2011 Nov;128(5):1077-85.e1-10. doi: 10.1016/j.jaci.2011.04.034. Epub 2011 May 25.

PMID:
21616524
18.

IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung.

Mattes J, Yang M, Siqueira A, Clark K, MacKenzie J, McKenzie AN, Webb DC, Matthaei KI, Foster PS.

J Immunol. 2001 Aug 1;167(3):1683-92.

19.

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.

Powrie F, Menon S, Coffman RL.

Eur J Immunol. 1993 Nov;23(11):3043-9.

PMID:
8223881
20.

Ursolic acid, a potential PPARĪ³ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.

Kim SH, Hong JH, Lee YC.

Eur J Pharmacol. 2013 Feb 15;701(1-3):131-43. doi: 10.1016/j.ejphar.2012.11.033. Epub 2012 Nov 28.

PMID:
23201068

Supplemental Content

Support Center